|
|||||
|
|
| 表柔比星为主的联合方案治疗非霍奇金淋巴瘤疗效观察 | |
| 引用本文： | 卞锦国,董戴玉,陈洁,刘晓莉. 表柔比星为主的联合方案治疗非霍奇金淋巴瘤疗效观察[J]. 中国肿瘤临床与康复, 2005, 12(2): 159-161 |
| 作者姓名： | 卞锦国 董戴玉 陈洁 刘晓莉 |
| 作者单位： | 上海第二医院科大学附属新华医院血液科,200001 |
| 摘 要： | 目的评估表柔比星为主的联合方案治疗非霍奇金淋巴瘤的疗效.方法治疗组采用CHOP-A与CHOP-B方案交替应用,对照组采用CHOP方案.治疗4个疗程以上,进行疗效评价.结果治疗组与对照组的治疗总有效率分别为91.1%与59.5%,两组差异有显著性.两组毒副反应差异无显著性.结论 CHOP-A与CHOP-B交替使用是非霍奇金淋巴瘤的高效、低毒的治疗方法. |
| 关 键 词： | 非霍奇金淋巴瘤/化学疗法 表柔比星 异环磷酰胺 |
| 文章编号： | 1005-8664(2005)02-0159-03 |
| 修稿时间： | 2004-08-14 |
Treatment of non-Hodgkin''''s lymphoma with combined regimen containing epirubicin as the main drug |
|
| BIAN Jin-guo,DONG Dai-yu,CHEN Jie,et al. Treatment of non-Hodgkin''''s lymphoma with combined regimen containing epirubicin as the main drug[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2005, 12(2): 159-161 | |
| Authors: | BIAN Jin-guo DONG Dai-yu CHEN Jie et al |
| Abstract: | Objective To evaluate the treatment of non-Hodgkin's lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.Methods The treatment group adopted CHOP-A/CHOP-B and the control group adopted CHOP regimen for over 4 treatment courses.The therapeutic efficacy was evaluated.Results The effective rate of the treatment group was 91.1% and that of the control group was 59.5%.There was significant difference between the two groups.No significant difference in side effect between the two groups was seen.Conclusion CHOP-A/CHOP-B is an effective regimen with low toxicity in the therapy of NHL. |
| Keywords: | Non-Hodgkin lymphoma/chemotherapy Epirubicin Ifosfamide |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |